Belgrade (b) rats have an autosomal recessive, microcytic, hypochromic anem
ia. Transferrin (Tf)-dependent iron uptake is defective because of a mutati
on in DMT1 (Nramp2), blocking endosomal iron efflux. This experiment of nat
ure permits the present study to address whether the mutation also affects
non-Tf-bound iron (NTBI) uptake and to use NTBI uptake compared to Tf-Fe ut
ilization to increase understanding of the phenotype of the b mutation. The
distribution of Fe-59(2+) into intact erythroid cells and cytosolic, strom
al, heme, and nonheme fractions was different after NTBI uptake vs. Tf-Fe u
ptake, with the former exhibiting less iron into heme but more into stromal
and nonheme fractions. Both reticulocytes and erythrocytes exhibit NTBI up
take. Only reticulocytes had heme incorporation after NTBI uptake. Properly
normalized, incorporation into b/b heme was similar to 20% of +/b, a decre
ase similar to that for Tf-Fe utilization. NTBI uptake into heme was inhibi
ted by bafilomycin A1, concanamycin, NH4Cl, or chloroquine, consistent with
the endosomal location of the transporter; cellular uptake was uninhibited
. NTBI uptake was unaffected after removal of Tf receptors by Pronase or de
pletion of endogenous Tf. Concentration dependence revealed that NTBI uptak
e into cells, cytosol, stroma, and the nonheme fraction had an apparent low
affinity for iron; heme incorporation behaved like a high-affinity process
, as did an expression assay for DMT1. DMT1 serves in both apparent high-af
finity NTBI membrane transport and the exit of iron from the endosome durin
g Tf delivery of iron in rat reticulocytes; the low-affinity membrane trans
porter, however, exhibits little dependence on DMT1. J. Cell. Physiol. 178:
349-358, 1999. (C) 1999 Wiley-Liss, Inc.